Real-time enrollment status for this central line infections clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 11:44 AM UTC
| NCT Number | NCT06822426 |
| Recruiting Status | Recruiting |
| Condition | Central Line Infections |
| Phase | PHASE3 |
| Target Enrollment | 200 participants |
| Active Locations | 17 sites in the US |
| Sponsor | CorMedix |
| Last Updated on CT.gov | May 20, 2026 (May 20, 2026) |
As of July 17, 2026: Clinical trial NCT06822426 is currently recruiting participants. This phase3 study for central line infections is actively seeking new participants at 17 locations across the United States. The study is sponsored by CorMedix. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06822426 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 17 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06822426 was last updated May 20, 2026 (May 20, 2026). HelloStudys verifies this status automatically.